“Compared with CO (n = 32), FO (n = 36) significantly reduced fasting insulin by -1.62 μIU/L (95%CI: -2.99, -0.26,) (p = 0.021) and HOMA-IR by -0.40 units (95%CI: -0.78, -0.02, p = 0.038).”
“Higher insulin and HOMA-IR at baseline were associated with greater reductions in the FO group (p < 0.001).”